Patient-reported outcomes in capmatinib-treated patients with METex14-mutated advanced NSCLC: Results from the GEOMETRY mono-1 study
Year: 2022
Type: article
Source: European Journal of Cancer
Institutions: University Hospital Cologne, University of California, Los Angeles, University Medical Center Groningen, University of Groningen, SingHealth, National University of Singapore, SingHealth Duke-NUS Academic Medical Centre, Duke-NUS Medical School, National Cancer Centre Singapore, Novartis (United States), Novartis (France), RTI Health Solutions, Massachusetts General Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4311255819
